EPIS® Právní systém | Plné znění

XXŘ&Xxxxxx;XXX&Xxxxxx; KOMISE (XX) 2016/1179

xx xxx 19. čxxxxxxx 2016,

xxxx&xxxxxx;x xx xxx &xxxxxx;čxxx xřxxxůxxxxx&xxxxxx; xěxxxxxxxxxxxxx&xxxxxx;xx pokroku mění xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (ES) č. 1272/2008 x&xxxx;xxxxxxxxxxx, xxxxčxx&xxxxxx;x&xxxxxx; a balení x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx;

(Xxxx x x&xxxxxx;xxxxxx pro XXX)

EVROPSKÁ XXXXXX,

x&xxxx;xxxxxxx na Smlouvu x&xxxx;xxxxxx&xxxxxx;x&xxxxxx; Evropské xxxx,

x&xxxx;xxxxxxx xx xxř&xxxxxx;xxx&xxxxxx; Evropského xxxxxxxxxx a Rady (XX) č.&xxxx;1272/2008 xx xxx 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx x&xxxx;xxěx&xxxxxx;, x&xxxx;xxěxě x&xxxx;xxx&xxxxxx;xx&xxxxxx; xxěxxxx 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxěxě xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1907/2006 (1), x&xxxx;xxxx&xxxxxx;xx na čl. 37 xxxx.&xxxx;5 xxxxxx&xxxxxx;xx xxř&xxxxxx;xxx&xxxxxx;,

xxxxxxxx x&xxxx;xěxxx xůxxxůx:

(1)

Č&xxxxxx;xx 3 xř&xxxxxx;xxxx XX xxř&xxxxxx;xxx&xxxxxx; (XX) č. 1272/2008 xxxxxxxx xxx xxxxxxx harmonizovaných xxxxxxxxxx&xxxxxx; a označení xxxxxxxčx&xxxxxx;xx x&xxxxxx;xxx. X&xxxx;xxxxxxx 3.1 xx xxxxxx xxxxxx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; x&xxxx;xxxxčxx&xxxxxx; xxxxxxxčx&xxxxxx;xx látek xx x&xxxxxx;xxxxě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx x&xxxx;č&xxxxxx;xxxxx 2 xž 5 xř&xxxxxx;xxxx I nařízení (XX) č.&xxxx;1272/2008. V tabulce 3.2 xx uveden xxxxxx harmonizovaných klasifikací x&xxxx;xxxxčxx&xxxxxx; nebezpečných látek xx základě xxxx&xxxxxx;xx&xxxxxx; xxxxxxxx&xxxxxx;xx x&xxxx;xř&xxxxxx;xxxx VI xxěxxxxx Xxxx 67/548/EHS (2).

(2)

Vzhledem x&xxxx;xxxx, žx směrnice 67/548/XXX xxxx x&xxxx;&xxxxxx;čxxxxx xx 1. června 2015 xxx&xxxxxx;xxx, xěxx xx x&xxxxxx;x xxx&xxxxxx;xxx i tabulka 3.2 x&xxxx;xř&xxxxxx;xxxx XX části 3. Aby xx x&xxxxxx;xx xxxxxxxx xřxxxxx x&xxxx;xxx&xxxxxx;xx xxxxxňxx&xxxxxx;x&xxxxxx; xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008, xxxěxx xx xxxxxx&xxxxxx; zrušení xxx&xxxxxx;x účinku xř&xxxxxx;xx xxž 1. června 2017.

(3)

Xxxxxxx&xxxxxx; agentuře xxx xxxxxxx&xxxxxx; látky (XXXX) xxxx v souladu x&xxxx;čx&xxxxxx;xxxx&xxxx;37 nařízení (ES) č.&xxxx;1272/2008 xřxxxxžxxx návrhy xx xxx&xxxxxx;, aktualizované xxxx zrušené xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x&xxxx;xxxxčxx&xxxxxx; xěxxxx&xxxxxx;xx x&xxxxxx;xxx. Xx základě xxxxxxxxxx x&xxxx;xěxxx návrhům, xxxx&xxxxxx; vydal X&xxxxxx;xxx xxx xxxxxxx&xxxxxx;x&xxxxxx; rizik (XXX) působící x&xxxx;x&xxxxxx;xxx Xxxxxxx&xxxxxx; agentury pro xxxxxxx&xxxxxx; x&xxxxxx;xxx, xxxxž x&xxxx;xřxxxx&xxxxxx;xxx x&xxxxxx;čxxxxěx&xxxxxx;xx stran, xx xxxxx&xxxxxx; zavést, xxxxxxxxxxxx či zrušit xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x&xxxx;xxxxčxx&xxxxxx; xěxxxx&xxxxxx;xx x&xxxxxx;xxx.

(4)

Xxxxx xxx x&xxxx;x&xxxxxx;xxx &xxxxx;xxxxx&xxxxx;, RAC xxxxxxxx xx xx&xxxxxx;x xěxxxx&xxxxxx;x stanovisku xx xxx 5.&xxxx;xxxxxxxx&xxxx;2013 klasifikovat xx xxxx toxickou xxx xxxxxxxxxx xxxxxxxxx 1&xxxx;X. Xx&xxxxxx;xx xxxxxxxx x&xxxx;xxxx, žx neexistuje xxxxxxx xxxxxxě xxxxxxxxx&xxxxxx; xxxxxxxxxxx xxxxx x&xxxx;xxxxxxx&xxxxxx; xxxxě, je xřxxx xxxxx&xxxxxx;xxxx xxxx celistvou xxxxxx (xxxxxxxx částic xěx&xxxxxx;&xxxxxx; xxxx xxxxx 1&xxxx;xx) x&xxxx;xx&xxxxxx;&xxxxxx;xxxxx xxxxxx (xxxxxxxx č&xxxxxx;xxxx xxx&xxxxxx;&xxxxxx; xxž 1&xxxx;xx). Xx xxxxx vhodné, xxx xxx xxxxxxx specifický xxxxxxxxxčx&xxxxxx; xxxxx (SCL) &xx;&xxxx;0,03 % pro xx&xxxxxx;&xxxxxx;xxxxx xxxxx x&xxxx;xxxxx&xxxxxx; xxxxxxxxxčx&xxxxxx; xxxxx (GCL) &xx;&xxxx;0,3 % xxx xxxxxxxxx formu.

(5)

Xxxxx xxx x&xxxx;x&xxxxxx;xxx obsahující xěď, xěxx xx x&xxxxxx;x xx přílohy VI xxř&xxxxxx;xxx&xxxxxx; č. 1272/2008 xxřxxxxx xxxxxxxxxxx&xxxxxx;xx&xxxxxx; xxxxxxxxxxx xxxxxxčxx&xxxxxx; xx stanoviscích XXX xx dne 4.&xxxx;xxxxxxxx&xxxx;2014, xxxxxxž xxxx x&xxxx;xxxxxxxxx xxxxxxxčx&xxxxxx; xěxxxx&xxxxxx; xůxxxx xxůxxxňxx&xxxxxx;x&xxxxxx; xxxx novou xxxxxxxxxxx. Xxxxxxxxx&xxxxxx; multiplikační xxxxxxx xxx dlouhodobou xxxxxxxčxxxx pro vodní xxxxxřxx&xxxxxx; by však xxxxxxxx x&xxxxxx;x xxxěxx, xxxxť xxžxxxx&xxxxxx; další xxxxxxxx&xxxxxx; x&xxxxxx;xxxxx RAC xxxxxxxx x&xxxx;xěxxxx&xxxxxx;x &xxxxxx;xxxůx x&xxxx;xxxxxxxě xxx vodní xxxxxřxx&xxxxxx; xxxxxxxxxxx&xxxxxx;x xx xxxxxx xxxěxx&xxxxxx; xxx&xxxxxx;, xx bylo xxxxxxxxxx x&xxxxxx;xxxx XXX předáno Xxxxxx.

(6)	Xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008 xx xxxxx xěxx x&xxxxxx;x xxxxx&xxxxxx;xxx&xxxxxx;x&xxxxxx;x xxůxxxxx xxěxěxx.

(7)

Xxxxžxx&xxxxxx;x&xxxxxx; xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx xxxxxxxxxx&xxxxxx; xx xxxěxx x&xxxxxx;x xxžxxxx&xxxxxx;xx xxxxx, xxxxxxž xxxxxxxxx&xxxxxx; budou xxxřxxxxxx určité časové xxxxx&xxxxxx; na xx, xxx přizpůsobili označování x&xxxx;xxxxx&xxxxxx; x&xxxxxx;xxx a směsí xxx&xxxxxx;x xxxxxxxxxx&xxxxxx;x x&xxxx;xxxxxxx xx&xxxxxx;xxx&xxxxxx;x&xxxxxx; x&xxxxxx;xxxx. Toto xxxxx&xxxxxx; xxxx xxxxěž xxxx&xxxxxx; x&xxxx;xxxx, aby xx xxxxxxxxx&xxxxxx; xxxxx xřxxxůxxxxx dalším legislativním xxxxxxxxxxx, xxxx&xxxxxx; vyplývají x&xxxx;xxx&xxxxxx;xx xxxxxxxxxxxx&xxxxxx;xx klasifikací x&xxxxxx;xxx, xxxř. xxxxxxxxxxx xxxxxxxx&xxxxxx;x x&xxxx;čx.&xxxx;22 písm. x) xxxx v článku 23 xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;1907/2006 (3), x&xxxx;čx&xxxxxx;xxx&xxxx;50 nařízení Xxxxxxx&xxxxxx;xx xxxxxxxxxx x&xxxx;Xxxx (XX) č.&xxxx;528/2012 (4) nebo x&xxxx;čx&xxxxxx;xxx&xxxx;44 xxř&xxxxxx;xxx&xxxxxx; Xxxxxxx&xxxxxx;xx parlamentu x&xxxx;Xxxx (XX) č.&xxxx;1107/2009 (5), x&xxxx;xxx je xxxxx xxxxxx.

(8)

X&xxxx;xxxxxxx s přechodnými xxxxxxxxx&xxxxxx;xx xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008, xxxx&xxxxxx; umožňují xxxxxxxxxě xxxž&xxxxxx;x xxx&xxxxxx; ustanovení xř&xxxxxx;xx, xx xxxxxxxxx&xxxxxx; xěxx x&xxxxxx;x xxžxxxx xxxž&xxxxxx;x xxx&xxxxxx; xxxxxxxxxxxx&xxxxxx; xxxxxxxxxxx x&xxxx;xxxxx&xxxxxx;xxx&xxxxxx;x&xxxxxx;x xxůxxxxx xxxxxxxxxě přizpůsobit xxxxčxx&xxxxxx;x&xxxxxx; x&xxxx;xxxxx&xxxxxx; xřxx xxůxxx x&xxxx;xxxxžxx&xxxxxx; xxxxxxx.

(9)	Xxxxřxx&xxxxxx; xxxxxxxx&xxxxxx; x&xxxxxx;xxx xxř&xxxxxx;xxx&xxxxxx;x jsou x&xxxx;xxxxxxx xx xxxxxxxxxxx x&xxxxxx;xxxx xř&xxxxxx;xxx&xxxxxx;xx čx&xxxxxx;xxxx&xxxx;133 xxř&xxxxxx;xxx&xxxxxx; (ES) č. 1907/2006,

XŘXXXXX XXXX NAŘÍZENÍ:

Čx&xxxxxx;xxx&xxxx;1

Xxř&xxxxxx;xxx&xxxxxx; (XX) č.&xxxx;1272/2008 xx xěx&xxxxxx; xxxxx:

1)	Xř&xxxxxx;xxxx XX xx xěx&xxxxxx; x&xxxx;xxxxxxx s přílohou tohoto xxř&xxxxxx;xxx&xxxxxx;.

2)	X&xxxx;xř&xxxxxx;xxxx VI xx xxx&xxxxxx;xxx tabulka 3.2.

Čx&xxxxxx;xxx&xxxx;2

1.&xxxx;&xxxx;&xxxx;Xxxx xxř&xxxxxx;xxx&xxxxxx; xxxxxxxx x&xxxx;xxxxxxxx xxxx&xxxxxx;x&xxxxxx;x xxxx xx vyhlášení x&xxxx;&Xxxxxx;řxxx&xxxxxx;x xěxxx&xxxxxx;xx Xxxxxxx&xxxxxx; xxxx.

2. Toto xxř&xxxxxx;xxx&xxxxxx; xx xxxžxxx xx 1. xřxxxx 2018.

Xxxxxxxxx&xxxxxx; čl. 1 xxxx.&xxxx;2 xx xxxžxxx xx 1.&xxxx;čxxxxx&xxxx;2017.

3.&xxxx;&xxxx;&xxxx;Xxxxxxxě od xxxxxxxx 2 mohou x&xxxxxx;x x&xxxxxx;xxx x&xxxx;xxěxx xřxx xxxx 1. xřxxxx 2018 xxxxxxxxxx&xxxxxx;xx, xxxxčxx&xxxxxx;xx x&xxxx;xxxxxx x&xxxx;xxxxxxx x&xxxx;xxř&xxxxxx;xxx&xxxxxx;x (XX) č. 1272/2008 xx xxěx&xxxxxx; xxxxxx xxř&xxxxxx;xxx&xxxxxx;.

Xxxx xxxxxxxx xx xxxxxxx v celém xxxxxxx x&xxxx;xxxxx použitelné xx xxxxx xxxxxxxxx státech.

V Bruselu xxx 19. xxxxxxxx 2016.

Xx Komisi

předseda

Jean-Claude XXXXXXX

(1)&xxxx;&xxxx;Xx. xxxx. X&xxxx;353, 31.12.2008, s. 1.

(2)&xxxx;&xxxx;Xxxxxxxx Rady 67/548/XXX xx dne 27. června 1967 x&xxxx;xxxxxxxxxx právních x&xxxx;xxxxxxxxx xxxxxxxx xxxxxxxxxx xx xxxxxxxxxxx, xxxxxx x&xxxx;xxxxxxxxxx xxxxxxxxxxxx xxxxx (Úř. xxxx. 196, 16.8.1967, x.&xxxx;1).

(3)&xxxx;&xxxx;Xxxxxxxx Evropského parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1907/2006 xx dne 18.&xxxx;xxxxxxxx&xxxx;2006 x&xxxx;xxxxxxxxxx, xxxxxxxxx, povolování x&xxxx;xxxxxxxxx xxxxxxxxxx xxxxx, x&xxxx;xxxxxxx Xxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxx, x&xxxx;xxxxx xxxxxxxx 1999/45/XX x&xxxx;x&xxxx;xxxxxxx xxxxxxxx Xxxx (XXX) x.&xxxx;793/93, xxxxxxxx Xxxxxx (XX) x.&xxxx;1488/94 x&xxxx;xxxxxxxx Rady 76/769/EHS, Xx. věst. X&xxxx;396, 30.12.2006, x.&xxxx;1.

(4) Nařízení Evropského parlamentu x&xxxx;Xxxx (XX) č. 528/2012 xx dne 22. května 2012 x&xxxx;xxxxxxxx biocidních přípravků xx xxx x&xxxx;xxxxxx xxxxxxxxx (Úř. xxxx. X&xxxx;167, 27.6.2012, s. 1).

(5)&xxxx;&xxxx;Xxxxxxxx Evropského xxxxxxxxxx x&xxxx;Xxxx (XX) č. 1107/2009 xx xxx 21. října 2009 x&xxxx;xxxxxxx xxxxxxxxx na xxxxxxx xxxxxxx na xxx x&xxxx;x&xxxx;xxxxxxx směrnic Xxxx 79/117/EHS a 91/414/EHS (Xx. xxxx. X&xxxx;309, 24.11.2009, x.&xxxx;1).

PŘÍLOHA

Tabulka 3.1, xxxxx 3, xxxxxxx XX, xxxxxxxx (ES) x.&xxxx;1272/2008 xx mění takto:

a)	položky xxxxxxxxxxxx indexovým xxxxxx 607-331-00-5 x&xxxx;609-066-00-0 xx xxxxxxx;

xxxxxxx xxxxxxxxxxxx indexovým xxxxxx 006-035-00-8, 029-002-00-X, 602-020-00-0, 602-033-00-1, 603-055-00-4, 604-030-00-0, 604-092-00-9, 605-013-00-0, 605-022-00-X, 606-014-00-9, 606-021-00-7, 607-056-00-0, 607-059-00-7, 607-157-00-X, 607-172-00-1, 607-375-00-5, 607-623-00-2, 613-166-00-X, 613-121-00-4, 616-011-00-4, 616-037-00-6 x&xxxx;616-207-00-X se xxxxxxxxx těmito xxxxxxxxxxx xxxxxxxxx:

Xxxxxxxx číslo	Mezinárodní identifikace xxxxxxxxxx xxxxx	Xxxxx ES	Číslo XXX	Xxxxxxxxxxx		Xxxxxxxx			Xxxxxxxxxx xxxxxxx. limity, xxxxxxxxxxxxx xxxxxxx	Xxxx.
Xxxxxxxx číslo	Mezinárodní identifikace xxxxxxxxxx xxxxx	Xxxxx ES	Číslo XXX	Xxxx tříd x&xxxx;xxxxxxxxx xxxxxxxxxxxxx	Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx xxxx	Xxxx xxxxxxxxxxxx xxx o nebezpečnosti	Kódy xxxxx. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxxxxxxxx xxxxxxx. limity, xxxxxxxxxxxxx xxxxxxx	Xxxx.
„006-035-00-8	xxxxxxxxxx (XXX); 2-(dimethylamino)-5,6-dimethylpyrimidin-4-yl xxxxxxxxxxxxxxxx	245-430-1	23103-98-2	Xxxx. 2 Xxxxx Xxx. 3 Xxxxx Xxx. 3 Skin Xxxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X351 X331 X301 X317 X400 X410	XXX08 XXX06 XXX09 Xxx	X351 X331 X301 X317 X410		X&xxxx;= 10 X&xxxx;= 100“
„029-002-00-X	xxxx xxxxx	215-270-7	1317-39-1	Xxxxx Tox. 4 Xxxxx Xxx. 4 Xxx Xxx. 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	H332 H302 H318 H400 H410	GHS07 GHS05 GHS09 Dgr	H332 H302 H318 H410		M = 100“
„602-020-00-0	1,2-xxxxxxxxxxxxx; xxxxxxxxxxxxxxxxx	201-152-2	78-87-5	Xxxx. Xxx. 2 Xxxx. 1X Xxxxx Xxx. 4* Xxxxx Tox. 4*	X225 X350 X332 X302	XXX02 XXX08 XXX07 Xxx	X225 X350 X332 X302“
„602-033-00-1	xxxxxxxxxxx	203-628-5	108-90-7	Xxxx. Liq. 3 Xxxxx Xxx. 4 Xxxx Irrit. 2 Xxxxxxx Xxxxxxx 2	H226 H332 H315 H411	GHS02 GHS07 GHS09 Wng	H226 H332 H315 H411“
„603-055-00-4	propylenoxid; 1,2-epoxypropan; xxxxxxxxxxxx	200-879-2	75-56-9	Xxxx. Xxx. 1 Carc. 1X Xxxx. 1B Acute Tox. 3 Xxxxx Xxx. 3 Xxxxx Xxx. 4 STOT XX 3 Xxx Xxxxx. 2	X224 X350 X340 X331 X311 X302 X335 X319	XXX02 XXX08 XXX06 Xxx	X224 X350 X340 X331 X311 X302 X335 X319“
„604-030-00-0	xxxxxxxx X; 4,4′-xxxxxxxxxxxxxxxxxxxx	201-245-8	80-05-7	Xxxx. 1X XXXX XX 3 Xxx Xxx. 1 Skin Xxxx. 1	H360F H335 H318 H317	GHS08 GHS05 GHS07 Dgr	H360F H335 H318 H317“
„604-092-00-9	dodecylfenol, xxxxxxxxxx; [1] 2-xxxxxxxxxxxx, rozvětvený; [2] 3-xxxxxxxxxxxx, rozvětvený; [3] 4-xxxxxxxxxxxx, xxxxxxxxxx; [4] xxxxxxxx xxxxxxxxxxxxxxxxxxx [5]	310-154-3 [1] [2] [3] [4] [5]	121158-58-5 [1] [2] [3] 210555-94-5 [4] 74499-35-7 [5]	Xxxx. 1X Xxxx Xxxx. 1C Eye Xxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X360X X314 X318 X400 X410	XXX08 XXX05 XXX09 Xxx	X360X X314 X410		X&xxxx;= 10 X&xxxx;= 10“
„605-013-00-0	xxxxxxxxxx (INN); (R)-1,2-O-(2,2,2-trichlorethyliden)-α-D-glukofuranosa; xxxxxxxxxxxxxxx; xxxxxxxxxxxxxxxxxxx	240-016-7	15879-93-3	Xxxxx Xxx. 4* Xxxxx Xxx. 3 STOT XX 3 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X332 X301 X336 X400 X410	XXX06 XXX09 Xxx	X332 X301 X336 X410		X&xxxx;= 10 X&xxxx;= 10	X“
„605-022-00-X	xxxxxxxx; xxxxxxxxxxxxx; 1,5-xxxxxxxxxx	203-856-5	111-30-8	Xxxxx Xxx. 2 Xxxxx Xxx. 3 XXXX XX 3 Xxxx Xxxx. 1X Xxxx. Sens. 1 Xxxx Xxxx. 1&xxxx;X Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 2	X330 X301 X335 X314 X334 X317 X400 X411	XXX06 XXX05 XXX08 XXX09 Xxx	X330 X301 X335 X314 X334 X317 X410	XXX071	XXXX XX 3; X335: 0,5 % ≤ X < 5 % X&xxxx;= 1“
„606-014-00-9	xxxxxxxxxxxx (ISO); 2-[2-(4-chlorfenyl)-2-fenylacetyl]indan-1,3-dion	223-003-0	3691-35-8	Repr. 1X Xxxxx Xxx. 1 Xxxxx Xxx. 1 Xxxxx Xxx. 1 XXXX XX 1 Xxxxxxx Xxxxx 1 Xxxxxxx Chronic 1	X360X X330 X310 X300 X372 (krev) H400 H410	GHS08 GHS06 GHS09 Dgr	H360D H330 H310 H300 H372 (xxxx) X410		Xxxx. 1X; X360X: X ≥ 0,003 % XXXX XX 1; X372 (xxxx): C ≥&xxxx;0,1 % STOT XX 2; H373 (xxxx): 0,01 % ≤ X &xx;&xxxx;0,1 % M = 1 X&xxxx;= 1“
„606-021-00-7	X-xxxxxx-2-xxxxxxxxxx; 1-methylpyrrolidin-2-on	212-828-1	872-50-4	Repr. 1X XXXX XX 3 Xxxx Xxxxx. 2 Xxx Irrit. 2	X360X*** X335 X315 X319	XXX08 XXX07 Xxx	X360X*** X335 X315 X319		XXXX XX 3; X335: X ≥ 10 %“
„607-056-00-0	xxxxxxxx (XXX); 4-xxxxxxx-3-(1-xxxxx-3-xxxxxxxx)-2X-xxxxxxx-2-xx; [1] (X)-4-xxxxxxx-3-(1-xxxxx-3-xxxxxxxx)-2X-xxxxxxx-2-xx; [2] (R)-4-hydroxy-3-(1-fenyl-3-oxobutyl)-2H-chromen-2-on; [3]	201-377-6 [1] 226-907-3 [2] 226-908-9 [3]	81-81-2 [1] 5543-57-7 [2] 5543-58-8 [3]	Xxxx. 1 A Acute Xxx. 1 Xxxxx Tox. 1 Xxxxx Tox. 2 STOT XX 1 Xxxxxxx Chronic 2	X360X X330 X310 X300 X372 (xxxx) X411	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X411		Xxxx. 1&xxxx;X; H360D: C ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): X ≥&xxxx;0,5 % XXXX XX 2; H373 (xxxx): 0,05 % ≤ X < 0,5 %“
„607-059-00-7	xxxxxxxxxxxx (XXX); 4-xxxxxxx-3-(1,2,3,4-xxxxxxxxxx-1-xxxxxx)-2X-xxxxxxx-2-xx	227-424-0	5836-29-3	Xxxx. 1B Acute Xxx. 2 Xxxxx Xxx. 3 Xxxxx Xxx. 2 XXXX XX 1 Xxxxxxx Xxxxxxx 1	X360X X330 X311 X300 X372 (krev) H410	GHS08 GHS06 GHS09 Dgr	H360D H330 H311 H300 H372 (krev) H410		Repr. 1X; X360X: C ≥&xxxx;0,003 % STOT XX 1; X372 (xxxx): X ≥&xxxx;1,0 % XXXX XX 2; X373 (xxxx) 0,1 % ≤ X < 1,0 % X&xxxx;= 10“
„607-157-00-X	difenakum (XXX); 3-[3-(xxxxxxx-4-xx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-4-xxxxxxx-2X-xxxxxxx-2-xx	259-978-4	56073-07-5	Xxxx. 1B Acute Xxx. 1 Xxxxx Tox. 1 Xxxxx Xxx. 1 STOT RE 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H360D H330 H310 H300 H372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410		Xxxx. 1B; H360D: C ≥&xxxx;0,003 % STOT RE 1; H372 (krev): X ≥ 0,02 % XXXX XX 2; X373 (xxxx): 0,002 % ≤ X &xx;&xxxx;0,02 % X&xxxx;= 10 X&xxxx;= 10“
„607-172-00-1	xxxxxxxxxx (XXX); 3-[3-(4′-xxxxxxxxxxx-4-xx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-4-xxxxxxx-2X-xxxxxxx-2-xx	259-980-5	56073-10-0	Xxxx. 1&xxxx;X Xxxxx Xxx. 1 Xxxxx Tox. 1 Xxxxx Xxx. 1 STOT XX 1 Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X360X X330 X310 X300 X372 (krev) H400 H410	GHS08 GHS06 GHS09 Dgr	H360D H330 H310 H300 H372 (xxxx) X410		Xxxx. 1 A; X360X: X ≥&xxxx;0,003 % XXXX RE 1; X372 (krev): X ≥&xxxx;0,02 % XXXX XX 2; X373 (xxxx): 0,002 % ≤ C < 0,02 % X&xxxx;= 10 M = 10“
„607-375-00-5	flokumafen (XXX); xxxxxxx směs xxx-4-xxxxxxx-3-[3-(4{[4-(xxxxxxxxxxxxxx)xxxxxx]xxx}xxxxx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-2X-xxxxxxx-2-xx x&xxxx;xxxxx-4-xxxxxxx-3-[3-(4{[4-(xxxxxxxxxxxxxx)xxxxxx]xxx}xxxxx)-1,2,3,4-xxxxxxxxxx-1-xxxxxx]-2X-xxxxxxx-2-xx	421-960-0	90035-08-8	Xxxx. 1B Acute Xxx. 1 Acute Tox. 1 Xxxxx Tox. 1 XXXX XX 1 Aquatic Acute 1 Xxxxxxx Xxxxxxx 1	X360X X330 X310 X300 X372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410		Xxxx. 1X; X360X: X ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): X ≥&xxxx;0,05 % XXXX RE 2; X373 (xxxx): 0,005 % ≤ X &xx;&xxxx;0,05 % X&xxxx;= 10 X&xxxx;= 10“
„607-623-00-2	diisobutyl-ftalát	201-553-2	84-69-5	Repr. 1X	X360Xx	XXX08 Xxx	X360Xx“
„613-166-00-X	xxxxxxxxxxx (XXX); 7-xxxxx-4-(xxxx-2-xx-1-xx)-6-(3,4,5,6-xxxxxxxxxxxxxxxxxxx)-1,4-xxxxxxxxxx-3(2X)-xx	—	103361-09-7	Xxxx. 1B Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X360X X400 X410	XXX08 XXX09 Xxx	X360X X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 1&xxxx;000 “
„613-121-00-4	xxxxxxxxxxxxx (XXX); 1-(2-chlorbenzensulfonyl)-3-(4,6-dimethyl-1,3,5-triazin-2-yl)močovina	265-268-5	64902-72-3	Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X400 X410	XXX09 Xxx	X410		X&xxxx;= 1 000 M = 100“
„616-011-00-4	X,X-xxxxxxxxxxxxxxxx	204-826-4	127-19-5	Xxxx. 1X Xxxxx Xxx. 4* Xxxxx Xxx. 4*	H360D*** H332 H312	GHS08 GHS07 Dgr	H360D*** H332 H312“
„616-037-00-6	acetochlor (XXX); X-(xxxxxxxxxxxx)-X-(2-xxxxx-6-xxxxxxxxxxx)-2-xxxxxxxxxxxxx	251-899-3	34256-82-1	Xxxx. 2 Xxxx. 2 Xxxxx Xxx. 4 XXXX XX 3 XXXX XX 2 Xxxx Xxxxx. 2 Xxxx Xxxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	H351 H361f H332 H335 H373 (xxxxxxx) X315 X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X351 X361x X332 X335 X373 (xxxxxxx) X315 X317 X410		X&xxxx;= 1&xxxx;000 X&xxxx;= 100“
„616-207-00-X	xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx; XXXX	—	32289-58-0 27083-27-8	Xxxx. 2 Xxxxx Tox. 2 Xxxxx Xxx. 4 XXXX RE 1 Xxx Xxx. 1 Xxxx Xxxx. 1X Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X351 X330 X302 X372 (xxxxxxx xxxxx) (xxxxxxxxx) X318 X317 X400 X410	XXX08 XXX06 XXX05 XXX09 Xxx	X351 X330 X302 X372 (xxxxxxx cesty) (vdechnutí) H318 H317 H410		M = 10 X&xxxx;= 10“

V souladu x&xxxx;xxxxxxxxxxxx xxxxxxxxxx xxxxx xx xxxxxxxx xxxx xxxxxxx:

Xxxxxxxx xxxxx	Xxxxxxxxxxx identifikace xxxxxxxxxx xxxxx	Xxxxx ES	Číslo CAS	Klasifikace		Označení			Specifické xxxxxxx. limity, multiplikační xxxxxxx	Xxxx.
Xxxxxxxx xxxxx	Xxxxxxxxxxx identifikace xxxxxxxxxx xxxxx	Xxxxx ES	Číslo CAS	Xxxx xxxx x&xxxx;xxxxxxxxx xxxxxxxxxxxxx	Xxxx xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Xxxx xxxxxxxxxxx xxxxxxx x&xxxx;xxxxxxxxxx xxxx	Xxxx standardních xxx x&xxxx;xxxxxxxxxxxxx	Xxxx doplň. xxxxxxxxxxxx xxx x&xxxx;xxxxxxxxxxxxx	Specifické xxxxxxx. limity, multiplikační xxxxxxx	Xxxx.
„005-020-00-3	xxxxxxxxxxx xxxxxxx, xxxxxxx; [1] xxxxxxxxxxx xxxxxxx tetrahydrát [2]	234-541-0 [1] 234-541-0 [2]	12008-41-2 [1] 12280-03-4 [2]	Xxxx. 1B	H360FD	GHS08 Dgr	H360FD“
„014-046-00-4	mikrovlákna E-skla xxxxxxxxxxxxxxxxx složení; [xxxxxxxx-xxxxxxx-xxxxxxxxx xxxxxx s náhodnou orientací x&xxxx;xxxxx xxxxxxxxxxxxxxxx xxxxxxxx (x&xxxx;% xxxxxxxxxxxx): XxX2&xxxx;50,0-56,0 %, Al2O3 13,0-16,0 %, X2X3&xxxx;5,8-10,0 %, Xx2X &xx;&xxxx;0,6 %, X2X &xx;&xxxx;0,4 %, XxX 15,0-24,0 %, XxX &xx;&xxxx;5,5 %, Xx2X3 &xx;&xxxx;0,5 %, F2 &xx;&xxxx;1,0 %. Proces: xxxxxxx xxxx xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx a rotačním xxxxxxxx. (Xxxxx xxxxxxxxxx xxxxx mohou xxx xxxxxxxx x&xxxx;xxxxxxx xxxxxxxxxxxxx; xxxxxx xxxxxxx xxxxxxxxxx xxxxxxx).]	—	—	Xxxx. 1B	H350i	GHS08 Dgr	H350i			A“
„014-047-00-X	skleněná xxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxxxx; [xxxxxxxx-xxxxxxx-xxxxxxxxx xxxxxx s náhodnou orientací x&xxxx;xxxxx xxxxxxxx (x&xxxx;% xxxxxxxxxxxx): SiO2 55,0-60,0 %, Xx2X3&xxxx;4,0-7,0 %, B2O3 8,0-11,0 %, XxX2&xxxx;0,0-4,0 %, Xx2X 9,5-13,5 %, X2X 0,0-4,0 %, XxX 1,0-5,0 %, XxX 0,0-2,0 %, Xx2X3 < 0,2 %, XxX 2,0-5,0 %, XxX 3,0-6,0 %, X2 &xx;&xxxx;1,0 %. Xxxxxx: xxxxxxx jsou xxxxxxxx xxxxxxxxxxxxxx xxxxxxxx x&xxxx;xxxxxxxx procesem. (Xxxxx xxxxxxxxxx xxxxx xxxxx xxx přítomny v nízkých xxxxxxxxxxxxx; xxxxxx procesů xxxxxxxxxx xxxxxxx).]	—	—	Xxxx. 2	X351 (xxxxxxxxx)	XXX08 Xxx	X351 (vdechnutí)			A“
„029-015-00-0	thiokyanatan xxxxx	214-183-1	1111-67-7	Xxxxxxx Xxxxx 1 Aquatic Xxxxxxx 1	X400 X410	XXX09 Xxx	X410	XXX032	X&xxxx;= 10“
„029-016-00-6	oxid xxxxxxx	215-269-1	1317-38-0	Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	H400 H410	GHS09 Wng	H410		M = 100“
„029-017-00-1	xxxxxxx-xxxxxxxxxxx xxxxxxxxx	215-572-9	1332-65-6	Xxxxx Xxx. 4 Xxxxx Xxx. 3 Aquatic Xxxxx 1 Xxxxxxx Chronic 1	X332 X301 X400 X410	XXX06 XXX09 Xxx	X332 X301 X410		X&xxxx;= 10“
„029-018-00-7	xxxxxxxxxxxx-xxxxx tetraměďnatý; [1] xxxxxxxxxxxx-xxxxx xxxxxxxxxxxx xxxxxx [2]	215-582-3 [1] 215-582-3 [2]	1333-22-8 [1] 12527-76-3 [2]	Xxxxx Xxx. 4 Aquatic Xxxxx 1 Xxxxxxx Xxxxxxx 1	X302 X400 X410	XXX07 XXX09 Xxx	X302 X410		X&xxxx;= 10“
„029-019-01-X	xxxxxx xxxxxx (potažené alifatickou xxxxxxxxx)	—	—	Xxxxx Tox. 3 Acute Xxx. 4 Xxx Irrit. 2 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	H331 H302 H319 H400 H410	GHS06 GHS09 Dgr	H331 H302 H319 H410		M = 10“
„029-020-00-8	xxxxxxxxx xxxxxxx – xxxxxxxx xxxxxxx (1:1)	235-113-6	12069-69-1	Xxxxx Xxx. 4 Xxxxx Tox. 4 Eye Xxxxx. 2 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X332 X302 X319 X400 X410	XXX07 XXX09 Xxx	X332 X302 X319 X410		X&xxxx;= 10“
„029-021-00-3	xxxxxxxx xxxxxxx	243-815-9	20427-59-2	Xxxxx Xxx. 2 Xxxxx Xxx. 4 Xxx Xxx. 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	X330 X302 X318 X400 X410	XXX06 XXX05 XXX09 Xxx	X330 X302 X318 X410		X&xxxx;= 10“
„029-022-00-9	xxxxxxxxxxx xxxxx; xxxxxxx xxxxxxxx xxxxxx měďnatého x&xxxx;xxxxxxxxx xxxxxxxxxx	—	8011-63-0	Xxxxx Xxx. 4 Eye Xxx. 1 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	H332 H318 H400 H410	GHS07 GHS05 GHS09 Dgr	H332 H318 H410		M = 10“
„029-023-00-4	xxxxx xxxxxxx, pentahydrát	231-847-6	7758-99-8	Acute Xxx. 4 Xxx Xxx. 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X302 X318 X400 X410	XXX07 XXX05 XXX09 Xxx	X302 X318 X410		X&xxxx;= 10“
„082-013-00-1	olověný xxxxxx; [xxxxxx xxxxxx &xx;&xxxx;1&xxxx;xx]	231-100-4	7439-92-1	Xxxx. 1&xxxx;X Xxxx.	X360XX X362	XXX08 Xxx	X360XX X362		Xxxx. 1&xxxx;X; X360X: X ≥ 0,03 %“
„082-014-00-7	xxxxxxxx xxxxx: [xxxxxx xxxxxx ≥&xxxx;1&xxxx;xx]	231-100-4	7439-92-1	Xxxx. 1&xxxx;X Xxxx.	X360XX X362	XXX08 Xxx	X360XX X362“
„605-040-00-8	xxxxxxxxxxxxxxx-3-xxxxxxxxxx-xxxxxxxxxxxxx (INCI); reakční xxxx 4-(4-xxxxxxx-4-xxxxxxxxxxxx)xxxxxxxx-3-xx-1-xxxxxxxxxxxx x&xxxx;3-(4-xxxxxxx-4-xxxxxxxxxxxx)xxxxxxxx-3-xx-1-xxxxxxxxxxxx; [1] 4-(4-xxxxxxx-4-xxxxxxxxxxxx)xxxxxxxx-3-xx-1-xxxxxxxxxxx; [2] 3-(4-xxxxxxx-4-xxxxxxxxxxxx)xxxxxxxx-3-xx-1-xxxxxxxxxxx [3]	- [1] 250-863-4 [2] 257-187-9 [3]	130066-44-3 [1] 31906-04-4 [2] 51414-25-6 [3]	Xxxx Xxxx. 1&xxxx;X	X317	XXX07 Xxx	X317“
„607-716-00-8	xxxxxxxxxxx (XXX); 3-[3-(4′-xxxxxxxxxxx-4-xx)-3-xxxxxxx-1-xxxxxxxxxxx]-4-xxxxxxx-2X-xxxxxxx-2-xx	249-205-9	28772-56-7	Xxxx. 1X Xxxxx Tox. 1 Xxxxx Xxx. 1 Xxxxx Xxx. 1 XXXX XX 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X360X X330 X310 X300 X372 (xxxx) X400 X410	XXX08 XXX06 XXX09 Xxx	X360X X330 X310 X300 X372 (xxxx) X410		Xxxx. 1B; X360X: X ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): X ≥ 0,005 % XXXX RE 2; X373 (krev): 0,0005 % ≤ C < 0,005 % X&xxxx;= 1 X&xxxx;= 1“
„607-717-00-3	xxxxxxxxxxx (XXX); 3-[3-(4′-xxxxxxxxxxx-4-xx)-1,2,3,4-xxxxxxxxxxxxxxxxxx-1-xx]-4-xxxxxxx-2X-1-xxxxxxxxxxxxxx-2-xx	—	104653-34-1	Xxxx. 1B Acute Xxx. 1 Xxxxx Xxx. 1 Xxxxx Xxx. 1 XXXX XX 1 Xxxxxxx Xxxxx 1 Xxxxxxx Xxxxxxx 1	X360X X330 X310 X300 X372 (krev) H400 H410	GHS08 GHS06 GHS09 Dgr	H360D H330 H310 H300 H372 (xxxx) X410	XXX070	Xxxx. 1X; X360X: X ≥&xxxx;0,003 % XXXX XX 1; X372 (xxxx): X ≥&xxxx;0,02 % XXXX XX 2; X373 (xxxx): 0,002 % ≤ X &xx;&xxxx;0,02 % X&xxxx;= 100 X&xxxx;= 100“
„607-718-00-9	perfluornonan-1-ová xxxxxxxx [1] x&xxxx;xxxx xxxxx [2] x&xxxx;xxxxxx [3] xxxx	206-801-3 [1] [2] [3]	375-95-1 [1] 21049-39-8 [2] 4149-60-4 [3]	Carc. 2 Xxxx. 1X Xxxx. Xxxxx Xxx. 4 Xxxxx Xxx. 4 STOT XX 1 Xxx Xxx. 1	X351 X360Xx X362 X332 X302 X372 (játra, brzlík, xxxxxxx) X318	XXX08 XXX07 XXX05 Xxx	X351 X360Xx X362 X332 X302 X372 (játra, brzlík, xxxxxxx) X318“
„607-719-00-4	xxxxxxxxxxxx-xxxxxx	201-545-9	84-61-7	Xxxx. 1X Xxxx Xxxx. 1	X360X X317	XXX08 XXX07 Xxx	X360X X317“
„608-067-00-3	3,7-xxxxxxxxxxxx-2,6-xxxxxxxxxx	225-918-0	5146-66-7	Xxxx. 1X	X340	XXX08 Xxx	X340“
„612-288-00-0	xxxxxxxxx (ISO); 5-butyl-2-ethylamino-6-methylpyrimidin-4-yl-dimethylsulfamát	255-391-2	41483-43-6	Carc. 2 Xxxx Xxxx. 1X Xxxxxxx Xxxxxxx 1	X351 X317 X410	XXX08 XXX07 XXX09 Xxx	X351 X317 X410		X&xxxx;= 1“
„612-289-00-6	xxxxxxxxxxx (XXX); (1X)-X-[4-xxxxx-2-(xxxxxxxxxxxxxx)xxxxx]-1-(1X-xxxxxxxx-1-xx)-2-xxxxxxxxxxxxxxxx	—	68694-11-1	Xxxx. 1X Xxxxx Xxx. 4 XXXX XX 2 Xxxx Xxxx. 1 Xxxxxxx Acute 1 Xxxxxxx Chronic 1	X360X X302 X373 (xxxxx) X317 X400 X410	XXX08 XXX07 XXX09 Xxx	X360X X302 X373 (játra) H317 H410		M = 1 X&xxxx;= 1“
„616-218-00-X	xxxxxxxxxxxxxxxx (XXX); N-[9-(dichlormethylen)-1,2,3,4-tetrahydro-1,4-methanonaftalen-5-yl]-3-(difluormethyl)-1-methyl-1H-pyrazol-4-karboxamid	—	1072957-71-1	Acute Xxx. 3 Xxxxx Xxx. 3 Xxxxxxx Acute 1 Xxxxxxx Xxxxxxx 1	H331 H301 H400 H410	GHS06 GHS09 Dgr	H331 H301 H410		M = 100 X&xxxx;= 100“
„616-219-00-5	xxxxxxxxx (ISO); X-{2-[3-xxxxx-5-(xxxxxxxxxxxxxx)xxxxxxx-2-xx]xxxxx}-2-(xxxxxxxxxxxxxx)xxxxxxxx	—	658066-35-4	Xxxxxxx Xxxxxxx 2	X411	XXX09	X411“
„616-220-00-0	xxxxxxxxxx (ISO); 1-[(4-xxxxxxxxxx)xxxxxx]-1-xxxxxxxxxxx-3-xxxxxxxxxxxxx	266-096-3	66063-05-6	Xxxxxxx Acute 1 Aquatic Xxxxxxx 1	X400 X410	XXX09 Xxx	X410		X&xxxx;= 1 M = 1“
„617-023-00-2	xxxx-xxxxxxxxxxxxxxxxx	200-915-7	75-91-2	Xxxx. 2	H341	GHS08 Wng	H341“

Plné znění - 32016R1179

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Plné znění - 32016R1179

Na co čekáte? Nečekejte už ani minutu. Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.